News
age related macular degeneration
Phase 2b clinical trials set for potential AMD treatment
More than one million Americans aged 40 and over are affected by geographic atrophy (otherwise known as advanced dry age-related macular degeneration), which currently has no available therapy that...
age-related macular degeneration
FDA approves first drug to treat geographic atrophy
Geographic atrophy typically affects people over the age of 50 and is one of the main causes of vision loss in the United States.
AMD
AI algorithm may be a helpful tool for determining progression of AMD
Artificial intelligence may be the key in helping doctors determine which patients with intermediate AMD are at a high risk of the disease progressing to geographic atrophy.
age-related macular degeneration
Lab-grown retinal cells indicate possibility of clinical trials
Researchers hope that these cells are ready to be studied in human clinical trials
age related macular degeneration
Reduced risk of developing macular degeneration associated with two common prescription drugs
Researchers examined data from 14 studies to determine the effect of drugs on the risk of developing AMD.
age-related macular degeneration
Simple carbs may increase risk of developing macular degeneration
Researchers at Tufts University in Boston have found a possible link between a diet high in simple carbohydrates and risk of developing age-related macular degeneration.
age-related macular degeneration
New bionic eye moving towards human trials
The latest hurdle that was jumped for the implantable device was the successful implantation in sheep.
age-related macular degeneration
New therapy being developed to help reverse vision loss
Researchers at the University of Toronto have developed a new technique of injecting healthy cells into eyes affected by vision loss due to age-related macular degeneration (AMD) or retinitis pigme...
age-related macular degeneration
Damaging DNA buildup in eyes of those with macular degeneration can lead to blindness
A recent study was published in the journal Science Advances which sheds light on how a build-up of damaging DNA in the eyes of people with macular degeneration can lead to blindness.